Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
CC transcript
|
|
BIOMIMETIC THERAPEUTICS, INC. (BMTI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2014 |
SC 13G/A
| AQR CAPITAL MANAGEMENT LLC reports a 0% stake in BioMimetic Therapeutics, Inc. |
| 02/14/2012 |
SC 13G/A
| Clearbridge Advisors, LLC reports a 7.1% stake in BioMimetic Therapeutics Inc Address of issuers principal executive offices: 389 A Nichol Mill Lane Franklin, TN 37067 United States Item 2a) Name of person filing: ClearBridge Advisors, LLC Item 2b) Address of principal business office: 620 8th Avenue New York, NY 10018 Item 2c) Citizenship: Delaware Limited Liability Corporation Item 2d) |
| 02/09/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 12/20/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/11/2011 |
SC 13G/A
| BIOMIMETIC THERAPEUTICS, INC. reports a 7.6% stake in BioMimetic Therapeutics Inc Address of issuers principal executive offices: 389 A Nichol Mill Lane Franklin, TN 37067 United States Item 2a) Name of person filing: ClearBridge Advisors, LLC Item 2b) Address of principal business office: 620 8th Avenue New York, NY 10018 Item 2c) Citizenship: Delaware Limited Liability Corporation Item 2d) |
| 02/12/2010 |
SC 13G/A
| BIOMIMETIC THERAPEUTICS, INC. reports a 0.7% stake in Biomimetic Therapeutics, Inc. |
| 02/12/2010 |
SC 13G/A
| BIOMIMETIC THERAPEUTICS, INC. reports a 9.8% stake in BioMimetic Therapeutics Inc Address of issuers principal executive offices: 389 A Nichol Mill Lane Franklin, TN 37067 United States Item 2a) Name of person filing: ClearBridge Advisors, LLC Item 2b) Address of principal business office: 620 8th Avenue New York, NY 10018 Item 2c) Citizenship: Delaware Limited Liability Corporation Item 2d) |
| 02/11/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/13/2009 |
SC 13G/A
| Clearbridge Advisors, LLC reports a 12.2% stake in BioMimetic Therapeutics Inc Address of issuers principal executive offices: 389 A Nichol Mill Lane Franklin, TN 37067 United States Item 2a) Name of person filing: ClearBridge Advisors, LLC Item 2b) Address of principal business office: 620 8th Avenue New York, NY 10018 Item 2c) Citizenship: Delaware Limited Liability Corporation Item 2d) |
|
|